See the DrugPatentWatch profile for Tofacitinib
What is tofacitinib citrate, and what is it used for?
Tofacitinib citrate is the salt form of the drug tofacitinib. It’s used as an oral therapy in inflammatory and autoimmune conditions (tofacitinib is the active medicine). Common clinical use is for diseases such as rheumatoid arthritis and other inflammatory disorders where the goal is to reduce immune-driven inflammation.
What does “citrate” mean in tofacitinib citrate?
“Citrate” refers to the drug being formulated as a salt with citric acid. This can help with manufacturing and drug stability and is typically about formulation rather than changing the drug’s core medical effect (tofacitinib is still the active agent).
How does tofacitinib work?
Tofacitinib works by inhibiting Janus kinase (JAK) signaling, which is part of the pathways that drive inflammation. By blocking these pathways, it reduces inflammatory activity associated with autoimmune disease.
Is tofacitinib citrate the same as tofacitinib (brand-name products)?
Yes—when people say “tofacitinib citrate,” they are usually referring to the medication where the active ingredient is tofacitinib, provided in citrate salt form. The key therapeutic ingredient is tofacitinib.
Safety and monitoring questions patients usually ask
People taking tofacitinib are typically monitored for infection risk and other immune-related side effects, since it suppresses signaling involved in immune responses. Patients also ask clinicians about blood tests and whether they need adjustments for specific health conditions or interacting medicines.
Patents and exclusivity: where to check the latest status
For current patent and litigation tracking related to tofacitinib and its formulations, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/